Oxford Nanopore Technologies Ltd - Asset Resilience Ratio

Latest as of June 2026: 7.45%

Oxford Nanopore Technologies Ltd (ONT) has an Asset Resilience Ratio of 7.45% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Oxford Nanopore Technologies Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

GBX42.10 Million
≈ $5.12K USD Cash + Short-term Investments

Total Assets

GBX565.40 Million
≈ $68.79K USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2012–2025)

This chart shows how Oxford Nanopore Technologies Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see total assets of Oxford Nanopore Technologies Ltd.

Liquid Assets Composition Over Time

This chart breaks down Oxford Nanopore Technologies Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Oxford Nanopore Technologies Ltd (ONT) total liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents GBX0.00 0%
Short-term Investments GBX42.10 Million 7.45%
Total Liquid Assets GBX42.10 Million 7.45%

Asset Resilience Insights

  • Limited Liquidity: Oxford Nanopore Technologies Ltd maintains only 7.45% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Oxford Nanopore Technologies Ltd Industry Peers by Asset Resilience Ratio

Compare Oxford Nanopore Technologies Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Abivax SA
PA:ABVX
Biotechnology 2.58%
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252
Biotechnology 2.03%
Neuren Pharmaceuticals Ltd
AU:NEU
Biotechnology 90.43%
Lifecome Biochemistry Co Ltd
SHE:002868
Biotechnology 4.69%
Pulike Biological Engineering
SHG:603566
Biotechnology 17.82%
Rocket Pharmaceuticals Inc
NASDAQ:RCKT
Biotechnology 14.00%
NEWRON PHARMACEUT. EO-20
XETRA:NP5
Biotechnology 41.67%
Upstream Bio, Inc.
NASDAQ:UPB
Biotechnology 64.70%

Annual Asset Resilience Ratio for Oxford Nanopore Technologies Ltd (2012–2025)

The table below shows the annual Asset Resilience Ratio data for Oxford Nanopore Technologies Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 11.92% GBX74.20 Million
≈ $9.03K
GBX622.50 Million
≈ $75.74K
-6.79pp
2024-12-31 18.71% GBX138.85 Million
≈ $16.89K
GBX742.05 Million
≈ $90.29K
+12.34pp
2023-12-31 6.37% GBX49.51 Million
≈ $6.02K
GBX777.06 Million
≈ $94.55K
-8.12pp
2022-12-31 14.49% GBX119.41 Million
≈ $14.53K
GBX823.89 Million
≈ $100.24K
-1.02pp
2021-12-31 15.52% GBX130.63 Million
≈ $15.89K
GBX841.87 Million
≈ $102.43K
-17.59pp
2018-12-31 33.11% GBX58.00 Million
≈ $7.06K
GBX175.19 Million
≈ $21.32K
+24.73pp
2017-12-31 8.38% GBX10.00 Million
≈ $1.22K
GBX119.31 Million
≈ $14.52K
-29.37pp
2016-12-31 37.75% GBX60.00 Million
≈ $7.30K
GBX158.94 Million
≈ $19.34K
-3.67pp
2015-12-31 41.42% GBX45.06 Million
≈ $5.48K
GBX108.77 Million
≈ $13.23K
-9.96pp
2014-12-31 51.38% GBX36.12 Million
≈ $4.39K
GBX70.30 Million
≈ $8.55K
+3.24pp
2013-12-31 48.14% GBX33.15 Million
≈ $4.03K
GBX68.87 Million
≈ $8.38K
+3.77pp
2012-12-31 44.37% GBX23.05 Million
≈ $2.80K
GBX51.95 Million
≈ $6.32K
--
pp = percentage points

About Oxford Nanopore Technologies Ltd

LSE:ONT UK Biotechnology
Market Cap
$21.17 Million
GBX174.00 Billion GBX
Market Cap Rank
#25032 Global
#245 in UK
Share Price
GBX178.00
Change (1 day)
+3.37%
52-Week Range
GBX104.50 - GBX183.00
All Time High
GBX716.00
About

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA. The company offers MinION Mk 1D, a portable device for DNA and RNA sequencing; and GridION and GridION Q, a compact bench top device that delivers a version… Read more